Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2081.9000
-0.30
(
-0.01
%)
NSE
Dec 01, 2025
15:31 PM
Volume:
753.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
11 Nov 2024
2081.90
-0.01%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2600
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,600/share.
Lupin Ltd. has an
average target
of 2328.00 from 10 brokers.
More from Lupin Ltd.
Recommended
IPO market heats up: Meesho and Aequs launch, six SME debuts on the calendar
|
01 Dec 2025, 05:15PM
Market closes flat, dragged by healthcare and realty sectors
Trendlyne Marketwatch |
01 Dec 2025, 04:14PM
Lupin expects normalization by September quarter
|
17 Apr 2020